•Organogenesis announced that the FDA has accepted for review its Biologics License Application (BLA) for ReNu, a treatment for symptomatic knee osteoarthritis.
•TechnipFMC was awarded a significant contract by Eni for the Baleine Phase 3 development offshore Côte d'Ivoire.
•The contract involves designing and manufacturing flexible flowlines and risers to connect wells to a new floating production unit at 1,200 meters depth.
•A securities fraud class action lawsuit has been filed against Futu Holdings in the Southern District of New York for investors who acquired securities between May 2023 and May 2026.
•Zoetis Inc. is facing a class action lawsuit alleging misleading statements about product performance and competitive position between January 2025 and May 2026.
•GuruFocus data suggests the stock is undervalued with a GF Value of $194.14 against a current price of $74.80.
•Peabody Energy is facing a securities class action lawsuit alleging federal law violations related to its flagship Centurion metallurgical coal asset operations.
•A securities class action lawsuit was filed against Veritone, Inc. following its admission that certain financial statements contained improper revenue accounting.
•Solstice CEO David Sewell defended the $14.5 billion acquisition of Element Solutions, calling it a strategic move for the semiconductor and AI infrastructure sectors.
•Solstice shares fell 15% following the deal announcement, which the CEO attributed to merger arbitrage trading rather than strategic concerns.
•Goldgroup Mining received the final order from the British Columbia Supreme Court approving the plan of arrangement and merger with Gold Resource Corporation.
•The merger arrangement is expected to close on or about July 17, 2026, subject to the satisfaction of remaining closing conditions.